T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 8.73 CNY -3.43% Market Closed
Market Cap: 4.5B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Teyi Pharmaceutical Group Co Ltd stock under the Base Case scenario is 12.84 CNY. Compared to the current market price of 8.73 CNY, Teyi Pharmaceutical Group Co Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
12.84 CNY
Undervaluation 32%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation Backtest
Teyi Pharmaceutical Group Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Teyi Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Teyi Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Teyi Pharmaceutical Group Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Teyi Pharmaceutical Group Co Ltd

Provide an overview of the primary business activities
of Teyi Pharmaceutical Group Co Ltd.

What unique competitive advantages
does Teyi Pharmaceutical Group Co Ltd hold over its rivals?

What risks and challenges
does Teyi Pharmaceutical Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Teyi Pharmaceutical Group Co Ltd.

Provide P/S
for Teyi Pharmaceutical Group Co Ltd.

Provide P/E
for Teyi Pharmaceutical Group Co Ltd.

Provide P/OCF
for Teyi Pharmaceutical Group Co Ltd.

Provide P/FCFE
for Teyi Pharmaceutical Group Co Ltd.

Provide P/B
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/S
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/GP
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/EBITDA
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/EBIT
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/OCF
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/FCFF
for Teyi Pharmaceutical Group Co Ltd.

Provide EV/IC
for Teyi Pharmaceutical Group Co Ltd.

Show me price targets
for Teyi Pharmaceutical Group Co Ltd made by professional analysts.

What are the Revenue projections
for Teyi Pharmaceutical Group Co Ltd?

How accurate were the past Revenue estimates
for Teyi Pharmaceutical Group Co Ltd?

What are the Net Income projections
for Teyi Pharmaceutical Group Co Ltd?

How accurate were the past Net Income estimates
for Teyi Pharmaceutical Group Co Ltd?

What are the EPS projections
for Teyi Pharmaceutical Group Co Ltd?

How accurate were the past EPS estimates
for Teyi Pharmaceutical Group Co Ltd?

What are the EBIT projections
for Teyi Pharmaceutical Group Co Ltd?

How accurate were the past EBIT estimates
for Teyi Pharmaceutical Group Co Ltd?

Compare the revenue forecasts
for Teyi Pharmaceutical Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Teyi Pharmaceutical Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Teyi Pharmaceutical Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Teyi Pharmaceutical Group Co Ltd compared to its peers.

Compare the P/E ratios
of Teyi Pharmaceutical Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Teyi Pharmaceutical Group Co Ltd with its peers.

Analyze the financial leverage
of Teyi Pharmaceutical Group Co Ltd compared to its main competitors.

Show all profitability ratios
for Teyi Pharmaceutical Group Co Ltd.

Provide ROE
for Teyi Pharmaceutical Group Co Ltd.

Provide ROA
for Teyi Pharmaceutical Group Co Ltd.

Provide ROIC
for Teyi Pharmaceutical Group Co Ltd.

Provide ROCE
for Teyi Pharmaceutical Group Co Ltd.

Provide Gross Margin
for Teyi Pharmaceutical Group Co Ltd.

Provide Operating Margin
for Teyi Pharmaceutical Group Co Ltd.

Provide Net Margin
for Teyi Pharmaceutical Group Co Ltd.

Provide FCF Margin
for Teyi Pharmaceutical Group Co Ltd.

Show all solvency ratios
for Teyi Pharmaceutical Group Co Ltd.

Provide D/E Ratio
for Teyi Pharmaceutical Group Co Ltd.

Provide D/A Ratio
for Teyi Pharmaceutical Group Co Ltd.

Provide Interest Coverage Ratio
for Teyi Pharmaceutical Group Co Ltd.

Provide Altman Z-Score Ratio
for Teyi Pharmaceutical Group Co Ltd.

Provide Quick Ratio
for Teyi Pharmaceutical Group Co Ltd.

Provide Current Ratio
for Teyi Pharmaceutical Group Co Ltd.

Provide Cash Ratio
for Teyi Pharmaceutical Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for Teyi Pharmaceutical Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for Teyi Pharmaceutical Group Co Ltd?

What is the current Free Cash Flow
of Teyi Pharmaceutical Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Teyi Pharmaceutical Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Teyi Pharmaceutical Group Co Ltd

Current Assets 965.1m
Cash & Short-Term Investments 303.8m
Receivables 124.5m
Other Current Assets 536.8m
Non-Current Assets 1.4B
Long-Term Investments 22.9m
PP&E 708.3m
Intangibles 688.7m
Other Non-Current Assets 22.8m
Current Liabilities 544.8m
Accounts Payable 35.2m
Accrued Liabilities 13.2m
Short-Term Debt 477.4m
Other Current Liabilities 19m
Non-Current Liabilities 35m
Other Non-Current Liabilities 35m
Efficiency

Earnings Waterfall
Teyi Pharmaceutical Group Co Ltd

Revenue
842.6m CNY
Cost of Revenue
-445.5m CNY
Gross Profit
397m CNY
Operating Expenses
-282.6m CNY
Operating Income
114.5m CNY
Other Expenses
-10.7m CNY
Net Income
103.7m CNY

Free Cash Flow Analysis
Teyi Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Teyi Pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
57/100
Profitability
Score

Teyi Pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Teyi Pharmaceutical Group Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
74/100
Solvency
Score

Teyi Pharmaceutical Group Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Teyi Pharmaceutical Group Co Ltd

Wall Street analysts forecast Teyi Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Teyi Pharmaceutical Group Co Ltd is 14.21 CNY with a low forecast of 14.07 CNY and a high forecast of 14.63 CNY.

Lowest
Price Target
14.07 CNY
61% Upside
Average
Price Target
14.21 CNY
63% Upside
Highest
Price Target
14.63 CNY
68% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Teyi Pharmaceutical Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Teyi Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Teyi Pharmaceutical Group Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

4.5B CNY

Dividend Yield

5.73%

Description

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Contact

GUANGDONG
Jiangmen
No. 9, No. 11, Changxing Road, Taicheng, Taishan City
+867505627588
www.tczy.com.cn

IPO

2014-07-31

Employees

1 200

Officers

Deputy General Manager & Vice Chairman of The Board
Mr. Songqing Xu
CFO, Deputy GM, Board Secretary & Director
Mr. Xiliang Chen
Deputy General Manager
Mr. Yongzhao Zhang

See Also

Discover More
What is the Intrinsic Value of one Teyi Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Teyi Pharmaceutical Group Co Ltd stock under the Base Case scenario is 12.84 CNY.

Is Teyi Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8.73 CNY, Teyi Pharmaceutical Group Co Ltd is Undervalued by 32%.

Back to Top